Correlation of natriuretic peptides and inferior vena cava size in patients with congestive heart failure

Vascular Health and Risk Management

Volumn 8, Issue 1, 2012, Pages 213-218

  Hebl, Virginia ^a   Zakharova, Marina Y ^a   Canoniero, Mariana ^a   Duprez, Daniel ^a   Garcia, Santiago ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Heart failure; Inferior vena cava; Natriuretic peptides

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; BIOLOGICAL MARKER; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM PRESSURE; HEART EJECTION FRACTION; HUMAN; INFERIOR VENA CAVA COLLAPSIBILITY; INFERIOR VENA CAVA SIZE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PRESSURE MEASUREMENT; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SEX DIFFERENCE; THORAX PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; AGED; BLOOD; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART ATRIUM FUNCTION; HEART FAILURE; HEART STROKE VOLUME; HEMODYNAMICS; INFERIOR CAVA VEIN; MIDDLE AGED; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; UNITED STATES;

AGED; ATRIAL FUNCTION, RIGHT; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MINNESOTA; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RETROSPECTIVE STUDIES; STROKE VOLUME; VENA CAVA, INFERIOR;

EID: 84863217049     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S30001     Document Type: Article

References (23)

1. Yusuf S, Reddi S, Ôunpuu S, Anand S. Global burden of cardiovascular diseases. Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104:2746-2753.
2. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Available from: http://www.acc.org/clinical/guidelines/failure/index.pdf. Accessed on March 20, 2012.
3. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventing strategies and comprehensive disease management. Am Heart J. 1997;133:703-712.
4. Whalley GA, Doughty RN, Gamble GD, et al. Pseudonormal mitral filling pattern predicts hospital re-admission in patients with congestive heart failure. J Am Coll Cardiol. 2002;39:1787-1795.
5. Wang CS, FitzGerald M, Schulzer M, et al. Does this dyspneic patient in the emergency department have congestive heart failure? JAMA. 2005;294:1944-1956.
6. Wiener RS, Welch G. Trends in the use of the pulmonary artery catheter in the United States,1993-2004. JAMA. 2007;298:423-429.
7. Lainchbury JG, Campbell E, Frampton CM, Yandle TG, Nicholls MG, Richards AM. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol. 2003;42(4):728-735.
8. Maisel AS, McCord J, Nowak RM, et al; Breathing Not Properly Multinational Study Investigators. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol. 2003;41(11):2010-2017.
9. Kirkpatrick JN, Vannan MA, Narula J, Lang RM. Echocardiography in heart failure: Applications, utility, and new horizons. J Am Coll Cardiol. 2007;50:381-396.
10. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
11. Pudil R, Tichy M, Praus R, Blaha V, Vojacek J. NT-proBNP and echocardiographic parameters in patients with acute heart failure. Acta Medica (Hradec Kralove). 2007;50(1):51-56.
12. Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of doppler echocardiography and tissue-doppler imaging in the estimation of left ventricular filing pressures: a comparative simultaneous dopplercatheterization study. Circulation. 2000;102:1788-1794.
13. Yu CM, Sanderson JE, Chan S, Yeung L, Hung YT, Woo KS. Right ventricular diastolic dysfunction in heart failure. Circulation. 1996;93:1509-1514.
14. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002;40:976-982.
15. Stein JH, Neumann A, Marcus RH. Comparison of estimates of right atrial pressure by physical examination and echocardiography in patients with congestive heart failure and reasons for discrepancies. Am J Cardiol. 1997;80:1615-1618.
16. Kirscher BJ, Himelman RB, Schiller NB. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol. 1990;66:493-496.
17. Kimura BJ, Shaw DJ, Agan DL, Amundson SA, Ping AC, DeMaria AN. Value of a cardiovascular limited ultrasound examination using a hand-carried ultrasound device on clinical management in an outpatient medical clinic. Am J Cardiol. 2007;100:321-325.
18. Jang T, Aubin C, Naunheim R, Char D. Ultrasonography of the internal jugular vein in patients with dyspnea without jugular venous distension on physical examination. Ann Emerg Med. 2004;44(2):160-168.
19. Hartmann F, Packer M, Coats AJ, et al. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a sub-study of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation. 2004;110:1780-1786.
20. Gackowski A, Isnard R, Golmard JL, et al. Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure. Eur Heart J. 2004;20:1788-1796.
21. Goonewardena SN, Gemignani A, Ronan A, et al. Comparison of handcarried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure. JACC Cardiovasc Imaging 2008;1:595-601.
22. Daniels LB, Maisel AL. Natriuretic peptides. J Am Coll Cardiol. 2007;50:2357-2368.
23. Galasko GIW, Lahiri A, Barnes SC, Collison P, Senior R. What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease? Eur Heart J. 2005;26:2269-2276.